322 related articles for article (PubMed ID: 31676244)
21. Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection.
Boussinesq M; Gardon J
Ann Trop Med Parasitol; 1997 Sep; 91(6):573-89. PubMed ID: 9425360
[TBL] [Abstract][Full Text] [Related]
22. Sociodemographics, Clinical Factors, and Biological Factors Associated with Loiasis in Endemic Onchocerciasis Areas in Southern Gabon.
Moutongo Mouandza R; Mourou JR; Moutombi Ditombi B; Roger Sibi Matotou H; Ekomi B; Bouyou-Akotet MK; Mawili-Mboumba DP
Am J Trop Med Hyg; 2023 Oct; 109(4):850-857. PubMed ID: 37339766
[TBL] [Abstract][Full Text] [Related]
23. Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.
Wanji S; Nji TM; Hamill L; Dean L; Ozano K; Njouendou AJ; Abong RA; Obie ED; Amuam A; Ekanya R; Ndongmo WPC; Ndzeshang BL; Fung EG; Nnamdi DB; Nkimbeng DA; Teghen S; Kah E; Piotrowski H; Forrer A; Khan JAM; Woode ME; Niessen L; Watson V; Njoumemi Z; Murdoch ME; Thomson R; Theobald S; Enyong P; Turner JD; Taylor MJ
Parasit Vectors; 2019 Dec; 12(1):574. PubMed ID: 31801631
[TBL] [Abstract][Full Text] [Related]
24. Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?
Pion SD; Clarke P; Filipe JA; Kamgno J; Gardon J; Basáñez MG; Boussinesq M
Parasitology; 2006 Jun; 132(Pt 6):843-54. PubMed ID: 16469200
[TBL] [Abstract][Full Text] [Related]
25. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.
Thomson MC; Obsomer V; Dunne M; Connor SJ; Molyneux DH
Lancet; 2000 Sep; 356(9235):1077-8. PubMed ID: 11009145
[TBL] [Abstract][Full Text] [Related]
26. Effects of a 3-day regimen of albendazole (800 mg daily) on Loa loa microfilaraemia.
Tsague-Dongmo L; Kamgno J; Pion SD; Moyou-Somo R; Boussinesq M
Ann Trop Med Parasitol; 2002 Oct; 96(7):707-15. PubMed ID: 12537632
[TBL] [Abstract][Full Text] [Related]
27. An Integrated District Mapping Strategy for Loiasis to Enable Safe Mass Treatment for Onchocerciasis in Gabon.
Ella SN; Ogoussan K; Gass K; Hundley L; Diggle PJ; Johnson O; Biamonte M; Atsame J
Am J Trop Med Hyg; 2021 Nov; 106(2):732-739. PubMed ID: 34781262
[TBL] [Abstract][Full Text] [Related]
28. In Southern Nigeria
Emukah E; Rakers LJ; Kahansim B; Miri ES; Nwoke BEB; Griswold E; Saka Y; Anagbogu I; Davies E; Ityonzughul C; D'Ambrosio M; Bakalar M; Fletcher DA; Nutman T; Kamgno J; Richards FO
Am J Trop Med Hyg; 2018 Jul; 99(1):116-123. PubMed ID: 29761763
[TBL] [Abstract][Full Text] [Related]
29. Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.
Bennuru S; Pion SD; Kamgno J; Wanji S; Nutman TB
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3180. PubMed ID: 25232954
[TBL] [Abstract][Full Text] [Related]
30. Familial Aggregation and Heritability of Loa loa Microfilaremia.
Eyebe S; Sabbagh A; Pion SD; Nana-Djeunga HC; Kamgno J; Boussinesq M; Chesnais CB
Clin Infect Dis; 2018 Feb; 66(5):751-757. PubMed ID: 29040446
[TBL] [Abstract][Full Text] [Related]
31. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
32. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
Bulman CA; Bidlow CM; Lustigman S; Cho-Ngwa F; Williams D; Rascón AA; Tricoche N; Samje M; Bell A; Suzuki B; Lim KC; Supakorndej N; Supakorndej P; Wolfe AR; Knudsen GM; Chen S; Wilson C; Ang KH; Arkin M; Gut J; Franklin C; Marcellino C; McKerrow JH; Debnath A; Sakanari JA
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003534. PubMed ID: 25700363
[TBL] [Abstract][Full Text] [Related]
33. Unusual Localization of Blood-Borne Loa loa Microfilariae in the Skin Depends on Microfilarial Density in the Blood: Implications for Onchocerciasis Diagnosis in Coendemic Areas.
Niamsi-Emalio Y; Nana-Djeunga HC; Chesnais CB; Pion SDS; Tchatchueng-Mbougua JB; Boussinesq M; Basáñez MG; Kamgno J
Clin Infect Dis; 2021 Jun; 72(Suppl 3):S158-S164. PubMed ID: 33909066
[TBL] [Abstract][Full Text] [Related]
34. Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon.
Kouam MK; Tchatchueng-Mbougua JB; Demanou M; Boussinesq M; Pion SD; Kamgno J
Parasit Vectors; 2013 Sep; 6(1):283. PubMed ID: 24289520
[TBL] [Abstract][Full Text] [Related]
35. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.
Opoku NO; Bakajika DK; Kanza EM; Howard H; Mambandu GL; Nyathirombo A; Nigo MM; Kasonia K; Masembe SL; Mumbere M; Kataliko K; Larbelee JP; Kpawor M; Bolay KM; Bolay F; Asare S; Attah SK; Olipoh G; Vaillant M; Halleux CM; Kuesel AC
Lancet; 2018 Oct; 392(10154):1207-1216. PubMed ID: 29361335
[TBL] [Abstract][Full Text] [Related]
36. Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).
Kamgno J; Pion SD; Tejiokem MC; Twum-Danso NA; Thylefors B; Boussinesq M
Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):777-85. PubMed ID: 17531279
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and intensity of Loa loa infection over twenty-three years in three communities of the Mbalmayo health district (Central Cameroon).
Mogoung-Wafo AE; Nana-Djeunga HC; Domche A; Fossuo-Thotchum F; Bopda J; Mbickmen-Tchana S; Djomo-Kamga H; Kamgno J
BMC Infect Dis; 2019 Feb; 19(1):146. PubMed ID: 30760228
[TBL] [Abstract][Full Text] [Related]
38. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis.
Boussinesq M; Gardon J; Gardon-Wendel N; Kamgno J; Ngoumou P; Chippaux JP
Am J Trop Med Hyg; 1998 Apr; 58(4):461-9. PubMed ID: 9574793
[TBL] [Abstract][Full Text] [Related]
39. Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
Abegunde AT; Ahuja RM; Okafor NJ
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011146. PubMed ID: 26771164
[TBL] [Abstract][Full Text] [Related]
40. Projected Number of People With Onchocerciasis-Loiasis Coinfection in Africa, 1995 to 2025.
Vinkeles Melchers NVS; Coffeng LE; Boussinesq M; Pedrique B; Pion SDS; Tekle AH; Zouré HGM; Wanji S; Remme JH; Stolk WA
Clin Infect Dis; 2020 May; 70(11):2281-2289. PubMed ID: 31304961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
